AbbVie

Biogen gets go-ahead for EU Humira launch in October

https://pharmaphorum.com/sales-marketing/biogen-gets-go-ahead-eu-humira-launch-october/

AbbVie to file long-acting psoriasis contender

https://pharmaphorum.com/news/abbvie-eyes-global-filings-next-gen-psoriasis-drug/

AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s

https://pharmaphorum.com/news/abbvie-immunoneurology-alzheimers/

Ready to pounce: Samsung joins Amgen with Humira biosimilar approval

https://pharmaphorum.com/news/samsung-bioepis-humira-biosimilar-approved-eu/

Janssen/AbbVie drug approved in graft-versus-host disease

https://pharmaphorum.com/news/imbruvica-drug-approved-graft-versus-host-disease/

AbbVie, Gilead target sick hepatitis C patients in EU

https://pharmaphorum.com/news/abbvie-gilead-hepatitis-c/

UK court overturns AbbVie Humira patents

https://pharmaphorum.com/news/uk-court-overturns-abbvie-humira-patents/

NICE rejects AbbVie/Roche CLL drug Venclyxto

https://pharmaphorum.com/news/nice-rejects-abbvie-cll-drug/

Ablynx files blood disorder drug in EU

https://pharmaphorum.com/news/ablynx-filed-blood-disorder-drug-eu/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search